Economic evaluation of low-dose computed tomography for lung cancer screening among high-risk individuals – evidence from Hungary based on the HUNCHEST-II study
Péter Rózsa, Anna Kerpel-Fronius, Mátyás Péter Murányi, Ágnes Rumszauer, Gabriella Merth, Zsolt Markóczy, Péter Csányi, Krisztina Bogos · 2024
Read Economic evaluation of low-dose computed tomography for lung cancer screening among high-risk individuals – evidence from Hungary based on the HUNCHEST-II study by Péter Rózsa, Anna Kerpel-Fronius, Mátyás Péter Murányi, Ágnes Rumszauer, Gabriella Merth, Zsolt Markóczy, Péter Csányi, Krisztina Bogos (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11616101.txt.
Description
Rózsa and seven co-authors weighed the economics of lung cancer screening in Hungary in twenty twenty-four. Lung cancer is the country's top cancer killer. Low-dose CT scans can catch small nodules early in heavy smokers, and a Hungarian trial, HUNCHEST-II, supplied real detection data.
The team modeled current and former smokers aged fifty to seventy-four over thirty years. Screening every two years added healthy life years at a cost per quality-adjusted year below Hungary's accepted threshold, so it counted as cost-effective. Annual screening looked even better value and dominated the two-year option on efficiency grounds. The authors conclude a national program is justified economically, with yearly scans ideal and two-yearly scans a cheaper fallback if funds are tight.
Catalog record
| CREATOR | Péter Rózsa, Anna Kerpel-Fronius, Mátyás Péter Murányi, Ágnes Rumszauer, Gabriella Merth, Zsolt Markóczy, Péter Csányi, Krisztina Bogos |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |